Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study on the Viral Kinetics of Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in HBeAg Positive Chronic Hepatitis B

NCT00226447 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.

NCT NCT00226447
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00226447 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study on the Viral Kinetics of Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in HBeAg Positive Chronic Hepatitis B
Lead sponsor
Chinese University of Hong Kong
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2002
Completion date
July 31, 2006
Enrollment
30
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b